Skip to main content
Top
Published in: Neurocritical Care 1/2010

01-08-2010 | Practical Pearl

Severe Leukoencephalopathy Following Acute Oxycodone Intoxication

Authors: Yazmin Morales Odia, Madhavi Jinka, Wendy C. Ziai

Published in: Neurocritical Care | Issue 1/2010

Login to get access

Abstract

Background

Post-opioid toxic encephalopathy is described associated with the synthetic opioid, methadone, and after heroin intoxication, (inhaled, injected or ingested).

Methods

We describe the clinical and radiologic findings of a 46-year-old man with oxycodone and oxycontin overdose who developed multifocal encephalopathy and severe cerebellitis causing acute obstructive hydrocephalus, and discuss the possible mechanisms involved.

Results

Brain MRI showed a non-vascular distribution of diffusion positive lesions in both cerebellar hemispheres and globi pallidi with preserved cerebral perfusion, suggesting an inflammatory process. Management required ventilatory support and intraventricular catheter placement.

Conclusions

To our knowledge, this is the first report of this condition associated with oxycodone and oxycontin ingestion. The occurrence of this rare toxic encephalopathy may be related to distribution patterns of opioid receptor subtypes, genetic susceptibility, sensitization, and other specific comorbidities.
Literature
1.
go back to reference Wolters EC, Wijngaarden GK, Stam FC, et al. Leukoencephalopathy after inhaling “heroin” pyrolysate. Lancet. 1982;2:1233–7.CrossRefPubMed Wolters EC, Wijngaarden GK, Stam FC, et al. Leukoencephalopathy after inhaling “heroin” pyrolysate. Lancet. 1982;2:1233–7.CrossRefPubMed
2.
go back to reference Zanin A, Masiero S, Severino MS, Calderone M, Da Dalt L, Laverda AM. A delayed methadone encephalopathy: clinical and neuroradiological findings. J Child Neurol. Epub 2009 Oct 6. Zanin A, Masiero S, Severino MS, Calderone M, Da Dalt L, Laverda AM. A delayed methadone encephalopathy: clinical and neuroradiological findings. J Child Neurol. Epub 2009 Oct 6.
3.
go back to reference Mills F, MacLennan SC, Devile CJ, Saunders DE. Severe cerebellitis following methadone poisoning. Pediatr Radiol. 2008;38(2):227–9.CrossRefPubMed Mills F, MacLennan SC, Devile CJ, Saunders DE. Severe cerebellitis following methadone poisoning. Pediatr Radiol. 2008;38(2):227–9.CrossRefPubMed
4.
go back to reference Celius EG, Andersson S. Leucoencephalopathy after inhalation of heroin: a case report. J Neurol Neurosurg Psychiatry. 1996;60(6):694–5.CrossRefPubMed Celius EG, Andersson S. Leucoencephalopathy after inhalation of heroin: a case report. J Neurol Neurosurg Psychiatry. 1996;60(6):694–5.CrossRefPubMed
5.
go back to reference Anselmo M, Campos Rainho A, do Carmo Vale M, et al. Methadone intoxication in a child: toxic encephalopathy? J Child Neurol. 2006;21(7):618–20.CrossRefPubMed Anselmo M, Campos Rainho A, do Carmo Vale M, et al. Methadone intoxication in a child: toxic encephalopathy? J Child Neurol. 2006;21(7):618–20.CrossRefPubMed
6.
go back to reference Robertson AS, Jain S, O’Neil RA. Spongiform leucoencephalopathy following intravenous heroin abuse: radiological and histopathological findings. Australas Radiol. 2001;45(3):390–2.CrossRefPubMed Robertson AS, Jain S, O’Neil RA. Spongiform leucoencephalopathy following intravenous heroin abuse: radiological and histopathological findings. Australas Radiol. 2001;45(3):390–2.CrossRefPubMed
7.
go back to reference Rizutto N, Morbin M, Ferrari S, et al. Delayed spongiform leukoencephalopathy after heroine abuse. Acta Neuropathol. 1997;94(1):87–90.CrossRef Rizutto N, Morbin M, Ferrari S, et al. Delayed spongiform leukoencephalopathy after heroine abuse. Acta Neuropathol. 1997;94(1):87–90.CrossRef
9.
go back to reference Package insert Oxycontin. Stamford, CT: Purdue Pharma L.P. 2007-11-05. Package insert Oxycontin. Stamford, CT: Purdue Pharma L.P. 2007-11-05.
10.
go back to reference Lalovic B, Kharasch E, Hoffer C, Risler L, Liu-Chen LY, Shen DD. Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites. Clin Pharmacol Ther. 2006;79(5):461–79.CrossRefPubMed Lalovic B, Kharasch E, Hoffer C, Risler L, Liu-Chen LY, Shen DD. Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites. Clin Pharmacol Ther. 2006;79(5):461–79.CrossRefPubMed
11.
go back to reference Ross FB, Smith MT. The intrinsic antinociceptive effects of oxycodone appear to be κ-opioid receptor mediated. Pain. 1997;73(2):151–7.CrossRefPubMed Ross FB, Smith MT. The intrinsic antinociceptive effects of oxycodone appear to be κ-opioid receptor mediated. Pain. 1997;73(2):151–7.CrossRefPubMed
12.
go back to reference Smith MT. Differences between and combinations of opioids re-visited. Curr Opin Anaesthesiol. 2008;21(5):596–601.CrossRefPubMed Smith MT. Differences between and combinations of opioids re-visited. Curr Opin Anaesthesiol. 2008;21(5):596–601.CrossRefPubMed
13.
go back to reference Shadrack J, Willoch F, Platzer S, et al. Opioid receptors in the human cerebellum: Evidence from (11C) diprenorphine PET, mRNA expression and autoradiography. Neuroreport. 1999;10(3):619–24.CrossRef Shadrack J, Willoch F, Platzer S, et al. Opioid receptors in the human cerebellum: Evidence from (11C) diprenorphine PET, mRNA expression and autoradiography. Neuroreport. 1999;10(3):619–24.CrossRef
14.
go back to reference Nozaki C, Saitoh A, Kamei J. Characterization of the antinociceptive effects of oxycodone in diabetic mice. Eur J Pharmacol. 2006;535(1–3):145–51.CrossRefPubMed Nozaki C, Saitoh A, Kamei J. Characterization of the antinociceptive effects of oxycodone in diabetic mice. Eur J Pharmacol. 2006;535(1–3):145–51.CrossRefPubMed
15.
go back to reference Nozaki C, Kamei J. Involvement of mu1-opioid receptor on oxycodone-induced antinociception in diabetic mice. Eur J Pharmacol. 2007;560(2–3):160–2.CrossRefPubMed Nozaki C, Kamei J. Involvement of mu1-opioid receptor on oxycodone-induced antinociception in diabetic mice. Eur J Pharmacol. 2007;560(2–3):160–2.CrossRefPubMed
16.
go back to reference Kriegstein AR, Shungu DC, Millar WS, et al. Leukoencephalopathy and raised brain lactate from heroin vapor inhalation (“chasing the dragon”). Neurology. 1999;53(8):1765–73.PubMed Kriegstein AR, Shungu DC, Millar WS, et al. Leukoencephalopathy and raised brain lactate from heroin vapor inhalation (“chasing the dragon”). Neurology. 1999;53(8):1765–73.PubMed
17.
go back to reference Chen Q, Lu JY, Lu BX, Yin RX, Yu J, Wang LN, Chui DH. Roles of cyclooxygenase 2/2′, 3′-cyclic nucleotide3′ phosphohydrolase in the oligodendrocyte apoptosis in heroin-induced spongiform leucoencephalopathy]. Zhonghua Yi Xue Za Zhi. 2008;88(25):1742–5.PubMed Chen Q, Lu JY, Lu BX, Yin RX, Yu J, Wang LN, Chui DH. Roles of cyclooxygenase 2/2′, 3′-cyclic nucleotide3′ phosphohydrolase in the oligodendrocyte apoptosis in heroin-induced spongiform leucoencephalopathy]. Zhonghua Yi Xue Za Zhi. 2008;88(25):1742–5.PubMed
Metadata
Title
Severe Leukoencephalopathy Following Acute Oxycodone Intoxication
Authors
Yazmin Morales Odia
Madhavi Jinka
Wendy C. Ziai
Publication date
01-08-2010
Publisher
Humana Press Inc
Published in
Neurocritical Care / Issue 1/2010
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-010-9373-y

Other articles of this Issue 1/2010

Neurocritical Care 1/2010 Go to the issue